We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
BETTENDORF, Iowa — Rivermont Collegiate in Bettendorf has announced that its early schooling will transition to a year-round model in August of 2026. School leaders said the change is based on ...
After federal judges blocked HHS’ 340B rebate pilot program from taking effect Jan. 1, HHS is discussing whether to reconsider the drug manufacturers’ plans, according to court documents. On Jan. 7, ...
The United States is expected to adopt the vaccine schedule used by Denmark, a much smaller country with universal health care. By Amelia Nierenberg and Maya Tekeli Amelia Nierenberg reported from ...
Medicare is launching a new pilot program that will require prior approval for 17 health services using artificial intelligence tools. The Wasteful and Inappropriate Service Reduction (WISeR) model is ...
MANVILLE, N.J.—Richard Onderko said he will never forget the terrifying Saturday morning back in 1971 when the water rose so swiftly at his childhood home here that he and his brother had to be ...
Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible ...
Chinese artificial intelligence startup MiniMax today announced the release of M2.1, a significantly enhanced performance for real-world complex tasks and agentic capabilities across more programming ...
Dec 23 (Reuters) - The U.S. Centers for Medicare and Medicaid Services on Tuesday unveiled a voluntary program to cover GLP-1 drugs for weight-loss and diabetes under Medicaid and Medicare Part D ...
As the January 1 implementation date approaches, here is a quick guide to the controversial new rebate model for the 340B Drug Pricing Program and the legal battle to stop it. The 340B Drug Pricing ...
The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...